Glucocorticoid receptors: finding the middle ground
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Glucocorticoids (GCs; referred to clinically as corticosteroids) are steroid hormones with potent anti-inflammatory and immune modulatory profiles. Depending on the context, these hormones can also mediate pro-inflammatory activities, thereby serving as primers of the immune system. Their target receptor, the GC receptor (GR), is a multi-tasking transcription factor, changing its role and function depending on cellular and organismal needs. To get a clearer idea of how to improve the safety profile of GCs, recent studies have investigated the complex mechanisms underlying GR functions. One of the key findings includes both pro- and anti-inflammatory roles of GR, and a future challenge will be to understand how such paradoxical findings can be reconciled and how GR ultimately shifts the balance to a net anti-inflammatory profile. As such, there is consensus that GR deserves a second life as a drug target, with either refined classic GCs or a novel generation of nonsteroidal GR-targeting molecules, to meet the increasing clinical needs of today to treat inflammation and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068 · cited 1×
“In vivo evidence supporting a role for GR dimerization in mediating the anti-inflammatory effects of GCs was provided by studies of GRdim/dim mice (57), which express a GR that is compromised in its ability to form dimers.”
Binder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898 · cited 2×
“For example, transrepression can involve a sequestration or squelching mechanism whereby the GR-targeted, DNA-bound TF detaches from the DNA, or a tethering mechanism whereby the GR remains associated with the DNA-bound TF (12).”
Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819 · cited 1×
“These include the following nonexclusive (and sometimes debated) mechanisms by which GR mediates repression of NF-κB transcriptional activity: (a) GR-mediated tethering (26, 27) or squelching (28) of the NF-κB p65 subunit, (b) recruitment of histone deacetylase 2 by deacetylated GR to NF-κB–dependent promoters (a spec…”
Ramamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638 · cited 1×
“These include the following nonexclusive (and sometimes debated) mechanisms by which GR mediates repression of NF-κB transcriptional activity: (a) GR-mediated tethering (26, 27) or squelching (28) of the NF-κB p65 subunit, (b) recruitment of histone deacetylase 2 by deacetylated GR to NF-κB–dependent promoters (a spec…”
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O’shea, J. J., Chrousos, G. P., & Bornstein, S. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0245com · Cited by 606 · cited 3×
“This notion is evidenced by GC-mediated enhancement of pro-inflammatory genes (23, 95), some examples of which are provided below.”
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559 · cited 1×
“In contrast, NF-κB–dependent induction of IκBα gene expression is not dependent on p-TEFb and is therefore not suppressed by GR (31, 32).”
Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding
Biddie, S. C., John, S., Sabo, P. J., Thurman, R. E., Johnson, T. A., Schiltz, R. L., Miranda, T. B., Sung, M.-H., Trump, S., Lightman, S. L., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.016 · Cited by 503
Lu, N. Z., & Cidlowski, J. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.025 · Cited by 455 · cited 1×
“Alternative splicing and translation start sites (TSSs) give rise to several GR transcripts (4–6), with the full-length GR α as the predominant active isoform.”
Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., & Clark, A. R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060336 · Cited by 430
The Incoherent Feedforward Loop Can Provide Fold-Change Detection in Gene Regulation
Goentoro, L., Shoval, O., Kirschner, M. W., & Alon, U. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.018 · Cited by 424 · cited 1×
“Incoherent loops are actually believed to be necessary for negative and positive pulse generation, accelerated responses, and sensing of fold change (85, 86).”
The glucocorticoid responses are shaped by molecular chaperones
Grad, I., & Picard, D. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.018 · Cited by 423 · cited 1×
“HSP70/90-based chaperone machinery functions with cochaperones to guarantee proper folding, maturation, nuclear accumulation, and DNA binding of the receptor (7, 8).”
Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription
Stavreva, D. A., Wiench, M., John, S., Conway-Campbell, B. L., McKenna, M. A., Pooley, J. R., Johnson, T. A., Voss, T. C., Lightman, S. L., & Hager, G. L. (2009) · Nature Cell Biology · doi:10.1038/ncb1922 · Cited by 375
Oakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373
Busillo, J. M., & Cidlowski, J. A. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.005 · Cited by 339 · cited 3×
“org Volume 127 Number 4 April 2017 sive inflammation (79, 84).”
Croxtall, J. D., Choudhury, Q., & Flower, R. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703272 · Cited by 332 · cited 1×
“These accessory proteins set in motion secondary signaling cascades such as inhibition of EGFR signaling through the actions of c-Src (1, 2, 88).”
Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses
Frank, M. G., Thompson, B. M., Watkins, L. R., & Maier, S. F. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.10.005 · Cited by 310 · cited 1×
“Acute (97, 98) or chronic (99–101) exposure to exogenous or endogenous GCs increases NLRP3 mRNA expression in microglia.”
Frank, M. G., Miguel, Z. D., Watkins, L. R., & Maier, S. F. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.008 · Cited by 303 · cited 2×
“Acute (97, 98) or chronic (99–101) exposure to exogenous or endogenous GCs increases NLRP3 mRNA expression in microglia.”
Vandevyver, S., Dejager, L., Tuckermann, J., & Libert, C. (2013) · Endocrinology · doi:10.1210/en.2012-2045 · Cited by 296
Munhoz, C. D., Lepsch, L. B., Kawamoto, E. M., Malta, M. B., Lima, L. D. S., Werneck Avellar, M. C., Sapolsky, R. M., & Scavone, C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4398-05.2006 · Cited by 274 · cited 1×
“Several other studies are in line with this timing model (73, 100, 105), including within the microvascular endothelium.”
Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome
Busillo, J. M., Azzam, K. M., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275370 · Cited by 264 · cited 4×
“Similarly, GC administration during ongoing inflammation can still induce pro-inflammatory gene and protein expression (96).”
InfluentialVoorhees, J. L., Tarr, A. J., Wohleb, E. S., Godbout, J. P., Mo, X., Sheridan, J. F., Eubank, T. D., & Marsh, C. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058488 · Cited by 236 · cited 2×
“Several studies showed neuron death and worsening of neurodegenerative disorders as a consequence of the pro-inflammatory effects after prolonged GC exposure (108–111).”
Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor
Clark, A. R., & Belvisi, M. G. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.004 · Cited by 209
Severe asthma: Advances in current management and future therapy
Barnes, P. J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.11.006 · Cited by 174 · cited 1×
“Indications range from short-term treatments for conditions such as skin rashes (14), seasonal allergic rhinitis (15) and relapses of multiple sclerosis (16) to long-term treatments for diseases such as severe asthma (17) and rheumatoid arthritis (18).”
Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor
Lu, N. Z., Collins, J. B., Grissom, S. F., & Cidlowski, J. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-07 · Cited by 160
Kleiman, A., Hübner, S., Parkitna, J. M. R., Neumann, A., Hofer, S., Weigand, M. A., Bauer, M., Schmid, W., Schütz, G., Libert, C., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-192112 · Cited by 152
Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus
Espinosa-Oliva, A. M., de Pablos, R. M., Villarán, R. F., Argüelles, S., Venero, J. L., Machado, A., & Cano, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.012 · Cited by 151
The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression
Reily, M. M., Pantoja, C., Hu, X., Chinenov, Y., & Rogatsky, I. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600919 · Cited by 149
Chinenov, Y., & Rogatsky, I. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.014 · Cited by 133 · cited 4×
“Rogatsky and colleagues recently demonstrated the importance of GRIP1 in homeostatic macrophage activation and function (34).”
InfluentialSamarasinghe, R. A., Di Maio, R., Volonte, D., Galbiati, F., Lewis, M., Romero, G., & DeFranco, D. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102821108 · Cited by 120
Tumor suppressor protein (p)53, is a regulator of NF-κB repression by the glucocorticoid receptor
Murphy, S. H., Suzuki, K., Downes, M., Welch, G. L., De Jesus, P., Miraglia, L. J., Orth, A. P., Chanda, S. K., Evans, R. M., & Verma, I. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114420108 · Cited by 93
Lannan, E. A., Galliher-Beckley, A. J., Scoltock, A. B., & Cidlowski, J. A. (2012) · Endocrinology · doi:10.1210/en.2012-1020 · Cited by 91 · cited 3×
“Furthermore, the expression of the serine protease inhibitor α 1-antichymotrypsin (encoded by serpin A3), a secreted acute-phase protein that is active in many inflammatory diseases, was enhanced by simultaneous challenge with DEX and TNF-α (77).”
Matthews, L., Berry, A., Ohanian, V., Ohanian, J., Garside, H., & Ray, D. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0154 · Cited by 88 · cited 1×
“Several other nongenomic GC signaling mechanisms have been described, including signaling through a membrane-bound form of GR in human peripheral blood mononuclear cells (PBMCs) (89), interactions with or regulation of the subcellular localization of particular kinases (90, 91), regulation of apoptosis by mitochondria…”
Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle
Gupte, R., Muse, G. W., Chinenov, Y., Adelman, K., & Rogatsky, I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309898110 · Cited by 70 · cited 1×
“Interestingly, GR does not affect Pol II recruitment or transcription initiation at elongation-controlled genes but promotes accumulation of a pause-inducing negative elongation factor in a GR interaction protein 1 (GRIP1) cofactor-dependent manner (33).”
Dittrich, A., Khouri, C., Sackett, S. D., Ehlting, C., Böhmer, O., Albrecht, U., Bode, J. G., Trautwein, C., & Schaper, F. (2012) · Hepatology · doi:10.1002/hep.24655 · Cited by 51 · cited 6×
“Remarkably, this increase is highly stimulus specific, as LPS-induced release of IL-6 remains suppressed by GCs (73).”
InfluentialGlucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., Hu, C. K., Tran, K. V., Miguel, Z. D., Chien, B. Y., & Sapolsky, R. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4705-12.2013 · Cited by 46
Cited by
Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases
Hardy, R. S., Raza, K., & Cooper, M. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0371-y · Cited by 265
Somvanshi, P. R., Mellon, S. H., Yehuda, R., Flory, J. D., Makotkine, I., Bierer, L., Marmar, C., Jett, M., & Doyle, F. J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00398.2019 · Cited by 55
Saitoh, B.-Y., Tanaka, E., Yamamoto, N., Kruining, D. V., Iinuma, K., Nakamuta, Y., Yamaguchi, H., Yamasaki, R., Matsumoto, K., & Kira, J.-I. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.04.008 · Cited by 47
Glucocorticoids mobilize macrophages by transcriptionally up-regulating the exopeptidase DPP4
Diaz-Jimenez, D., Petrillo, M. G., Busada, J. T., Hermoso, M. A., & Cidlowski, J. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010894 · Cited by 37
“These effects may depend on the type of inflammatory stimulus (10) and/or the timing of treatment (11), thus modulating the balance of the cellular state toward a net pro-inflammatory or anti-inflammatory state (7).”
BackgroundInteraction mechanisms between major depressive disorder and non-alcoholic fatty liver disease
Shao, Q., Wu, Y., Ji, J., Xu, T., Yu, Q., Ma, C., Liao, X., Cheng, F., & Wang, X. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.711835 · Cited by 32
“Body responses to GC depend on GC concentrations, physiological states of the body’s immune systems, and duration of stimulation (acute or chronic), among others (40).”
Background
Metadata
- Authors
- Desmet, S. J., & De Bosscher, K.
- Venue
- Journal of Clinical Investigation
- Published
- 2017-03-20
- Volume
- 127
- Issue
- 4
- Pages
- 1136-1145
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2596585859
- Cited by
- 147
- References
- 41
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.